Search Results

ivWatch, LLC, the IV safety company, unveiled a packed lineup of fall conference exhibitions and speaking engagements, including the Association for Vascular Access 2023 Conference in Portland, Oregon, American Nurses Credentialing Center’s National Magnet & Pathway to Excellence Conferences in Chicago, IV Summit 23 from IVTEAM in Nottingham, England, and IV Therapy Summit in London.

ivWatch, LLC, a leader in IV safety and inventor of the first and only continuous IV infiltration detection technology, has been awarded a sole source group purchasing agreement with Premier, Inc. through its KIINDO pediatric performance group and collaborative.

US-based company sees UK market as critical to adoption

ivWatch, LLC, inventor of the first and only continuous IV infiltration detection technology, announces the appointment of Kathy Cox to Chief Financial Officer.

ivWatch’s Family of IV Site Monitoring Products Now Available to More Than 4,000 Premier Hospitals with New Three-Year Agreement

Today, ivWatch, LLC, a leading medical device manufacturer of biosensors that detect IV infiltration and extravasation events, received approval from the National Institute for Occupational Safety and Health (NIOSH), a part of the Centers for Disease Control and Prevention (CDC), to produce surgical N95 respirators.

ivWatch, LLC, provider of continuous monitoring devices focused on improving patient safety and the effectiveness of intravenous (IV) therapy, today announced the issuance of two new patents in Japan and Australia, increasing the company’s patent portfolio to 31. ivWatch patented technology works in partnership with clinicians to reduce the harm

ivWatch, LLC, a pioneer in biosensor technology, has received FDA clearance for its new SmartTouchTM disposable sensor for the early detection of peripheral IV infiltration and extravasation events.

Janz to serve as the government supplier in the United States of ivWatch technology to increase availability to patients

ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, announced the CE marking of the ivWatch Model 400.